BioCentury | Aug 22, 2016
Company News

Trovagene sales and marketing update

...a non-invasive molecular diagnostic to detect the BRAF V600E mutation in urinary cfDNA; and Trovera KRAS...
BioCentury | Sep 16, 2013
Clinical News

Cf-BRAF: Clinical trial start

...researchers at the University of Southern California will begin a clinical trial to evaluate Trovagene's cf-KRAS...
BioCentury | Sep 16, 2013
Clinical News

Cf-KRAS: Clinical trial start

...researchers at the University of Southern California will begin a clinical trial to evaluate Trovagene's cf-KRAS...
...to monitor therapy response in <100 mCRC patients. Trovagene Inc. (NASDAQ:TROV), San Diego, Calif. Product: Cf-KRAS...
BioCentury | Sep 16, 2013
Clinical News

Cf-PIK3CA: Clinical trial start

...researchers at the University of Southern California will begin a clinical trial to evaluate Trovagene's cf-KRAS...
Items per page:
1 - 4 of 4